Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 57 out of 100. Long-term cohort studies

Topic: Risk, prevention and care in population studies

Plain-language summary

Background Current dementia risk scores have had limited success in consistently identifying at-risk individuals across different ages and geographical locations. Objective We aimed to develop and validate a novel dementia risk score for a midlife UK population, using two cohorts: the UK Biobank, and UK Whitehall II study. Methods We divided the UK Biobank cohort into a training (n=176 611, 80%) and test sample (n=44 151, 20%) and used the Whitehall II cohort (n=2934) for external validation.

What this study adds

Evidence grade: Moderate

The record lists 176 participants. This study developed and tested a new tool to estimate a person's risk of developing dementia in midlife, using data from two large UK groups. Reported effect size: AUC 0.77.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Anatürk, M., Patel, R., Ebmeier, K. P., Georgiopoulos, G., Newby, D., Topiwala, A., et al. (2023). Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts. BMJ mental health. https://doi.org/10.1136/bmjment-2023-300719

Vancouver

Anatürk M, Patel R, Ebmeier KP, Georgiopoulos G, Newby D, Topiwala A, et al. Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts. BMJ mental health. 2023. doi:10.1136/bmjment-2023-300719. PMID: 37603383.

BibTeX

@article{anaturk2023-37603383,
  author  = {Anatürk, M. and Patel, R. and Ebmeier, K. P. and Georgiopoulos, G. and Newby, D. and Topiwala, A. and de Lange, A. G. and Cole, J. H. and others},
  title   = {{Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts}},
  journal = {BMJ mental health},
  year    = {2023},
  doi     = {10.1136/bmjment-2023-300719},
  pmid    = {37603383},
  url     = {https://doi.org/10.1136/bmjment-2023-300719}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This study developed and tested a new tool to estimate a person's risk of developing dementia in midlife, using data from two large UK groups. Such a risk score could help identify people who might benefit from closer monitoring or preventive steps, though it does not itself prevent or treat dementia.

Study details

How this study scored 57/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 2 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 4 of 7; Citations per year 3 of 5; Impact for its field and year 4 of 6; Cited by studies here 2 of 6; Still being cited 2 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multicenter collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 57 of 100.57 of 100 points earned43 not earned

Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (BMJ mental health)
Journal's citation record 0 / 4 BMJ Mental Health: journal h-index 26 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 2 / 4 176 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 49 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 9.8 citations a year over 5 year(s) since 2023
Impact for its field and year 4 / 6 Cited 8.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 2 / 6 Cited by 7 other studies in this library
Still being cited 2 / 4 Cited 46 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Sana Suri: h-index 29 (OpenAlex, whole career)
Institution's track record 2 / 3 University of Oxford: institution h-index 2,205 (OpenAlex)
Multicenter collaboration 3 / 3 OpenAlex lists 14 institution(s) in 5 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 37603383)
Free to read 2 / 2 Free to read
Total 57 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.

Later studies that cite this one

7 studies in the alzhub library list this one in their references.

Related studies in Long-term cohort studies from nearby years

Also tagged “prevalence”

1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Long-term cohort studies

See all studies in Long-term cohort studies →